In turn, Li et al. demonstrated that either HJURP or Kruppel-like factor 11 (KLF11) silencing inhibited glioma cell proliferation and migration, while HJURP overexpression partially rescued these effects in cells deficient in KLF11 (Li et al., 2022). This evidence concerns the gene HJURP and central nervous system cancer.